Endpoints News
Integrating clinical AI within hospitals Read in browser
Endpoints News
Thursday, 11 June 2026
Thank you for reading, dupa dupackia!
basic
UPGRADE
The Endpoints 100: Despite all the turmoil, biotech is having a moment
A year ago, biotech was in its bleakest stretch in a decade. Now IPOs are rebounding and China deals are heating up. John Carroll and a panel of industry leaders dig into the latest Endpoints 100 results and uncover what’s next for the sector.
Costs go up
We’re getting our first signs of where healthcare costs are heading next year. 
According to a survey of actuaries at 27 health plans covering employers and individuals on the exchanges released today, PwC estimates that healthcare costs will rise 9% in 2027. 
PwC says that’s a higher expected rate of growth than we’ve seen in the last 17 years —and the consulting firm doesn’t expect that to be a “temporary spike.” 
The forces driving up healthcare spending are likely familiar if you’ve been reading our newsletter over the last year: AI tools are helping providers get more revenue, consolidation is driving up payment rates, pharmacy and behavioral health costs are rising, and arbitration via the No Surprises Act is leading to more out-of-network reimbursements than plans anticipated. 
At this rate, PwC estimates annual healthcare spending will hit $9 trillion in 2035, up from $5.3 trillion in 2024.
In terms of what might bring down costs, the report mentions improving the accuracy of payments (but not denying claims!) and better managing pharmacy expenses, particularly related to GLP-1s and specialty drugs. 
I’m told all the time that there’s urgency to curbing rising healthcare costs. But even as reports detail just how much spending is growing year to year, it’s been harder for me to discern what it’ll take to really see that change — and which organizations (employers or otherwise) will take the drastic steps that might be needed. In the meantime, as a healthcare consumer, I worry about how exposed I’ll be to these costs. 
- Lydia
Here’s what’s new
How K Health moved AI chatbots into hospitals
Star­tups that fash­ion them­selves as AI doc­tors that pa­tients can chat with have gained trac­tion over the last year.

One of these startups, K Health, gives health systems a way to retain and handle more patients by equipping them with a system they can brand as their own. 
Never gonna happen
49 The percentage of health plans that don't cover GLP-1 weight loss drugs for obesity and say they would not at any price, according to pharmacy benefits consultancy Pharmaceutical Strategies Group’s annual report on drug benefit design. PSG surveyed more than 200 leaders representing employers, health plans, and unions with a median of 14,000 covered members.
This week in health Тech
Talkspace launched a mental health chatbot for patients to speak with for $19.99 a month, joining other virtual therapy companies like Headspace and Lyra Health.
Novo Nordisk's popular weight loss drugs could lead the company deeper into longevity, CEO Mike Doustdar told Bloomberg. “If it is true that semaglutide slows down a lot of those conditions as a molecule, then maybe whether we like it or not, we are already in a bit of a longevity game,” Doustdar said. “We’re sitting in the middle of fully understanding that, and of course, exploring that.”
Hinge Health added orthopedic surgeons to its in-person provider network, as the company builds out its presence in musculoskeletal care.
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter linkedin
Worldwide made. Thanks for reading.
Unsubscribe preferences
Unsubscribe from all newsletters
FT Specialist Logo A service from the Financial Times